• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Malin修复作为拉福拉病基因治疗概念验证。

Malin restoration as proof of concept for gene therapy for Lafora disease.

作者信息

Varea Olga, Guinovart Joan J, Duran Jordi

机构信息

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona 08028, Spain.

出版信息

Brain Commun. 2022 Jun 23;4(4):fcac168. doi: 10.1093/braincomms/fcac168. eCollection 2022.

DOI:10.1093/braincomms/fcac168
PMID:35813879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9260307/
Abstract

Lafora disease is a fatal neurodegenerative childhood dementia caused by loss-of-function mutations in either the laforin or malin gene. The hallmark of the disease is the accumulation of abnormal glycogen aggregates known as Lafora bodies (LBs) in the brain and other tissues. These aggregates are responsible for the pathological features of the disease. As a monogenic disorder, Lafora disease is a good candidate for gene therapy-based approaches. However, most patients are diagnosed after the appearance of the first symptoms and thus when LBs are already present in the brain. In this context, it was not clear whether the restoration of a normal copy of the defective gene (either laforin or malin) would prove effective. Here we evaluated the effect of restoring malin in a malin-deficient mouse model of Lafora disease as a proof of concept for gene replacement therapy. To this end, we generated a malin-deficient mouse in which malin expression can be induced at a certain time. Our results reveal that malin restoration at an advanced stage of the disease arrests the accumulation of LBs in brain and muscle, induces the degradation of laforin and glycogen synthase bound to the aggregates, and ameliorates neuroinflammation. These results identify malin restoration as the first therapeutic strategy to show effectiveness when applied at advanced stages of Lafora disease.

摘要

拉福拉病是一种致命的儿童神经退行性痴呆,由拉福林或malin基因的功能丧失突变引起。该疾病的标志是大脑和其他组织中出现异常糖原聚集体,即所谓的拉福拉小体(LBs)。这些聚集体是该疾病病理特征的成因。作为一种单基因疾病,拉福拉病是基于基因治疗方法的良好候选对象。然而,大多数患者在首次出现症状后才被诊断出来,此时大脑中已经存在拉福拉小体。在这种情况下,尚不清楚恢复缺陷基因(拉福林或malin)的正常拷贝是否会被证明有效。在此,我们评估了在拉福拉病的malin缺陷小鼠模型中恢复malin的效果,以此作为基因替代疗法概念验证。为此,我们培育了一种malin缺陷小鼠,其中malin的表达可在特定时间被诱导。我们的结果显示,在疾病晚期恢复malin可阻止大脑和肌肉中拉福拉小体的积累,诱导与聚集体结合的拉福林和糖原合酶的降解,并改善神经炎症。这些结果表明,在拉福拉病晚期应用时,恢复malin是首个显示出有效性的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/5287ba85a47a/fcac168f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/ab8e3ffb7a26/fcac168ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/9d424fc56ea0/fcac168f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/f194087aba3c/fcac168f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/e6b6a13d0139/fcac168f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/d049a57ff45c/fcac168f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/defd6d26da16/fcac168f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/c7332a52fbb8/fcac168f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/794650814582/fcac168f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/5287ba85a47a/fcac168f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/ab8e3ffb7a26/fcac168ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/9d424fc56ea0/fcac168f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/f194087aba3c/fcac168f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/e6b6a13d0139/fcac168f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/d049a57ff45c/fcac168f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/defd6d26da16/fcac168f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/c7332a52fbb8/fcac168f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/794650814582/fcac168f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/9260307/5287ba85a47a/fcac168f8.jpg

相似文献

1
Malin restoration as proof of concept for gene therapy for Lafora disease.Malin修复作为拉福拉病基因治疗概念验证。
Brain Commun. 2022 Jun 23;4(4):fcac168. doi: 10.1093/braincomms/fcac168. eCollection 2022.
2
Lafora disease: Current biology and therapeutic approaches.拉佛拉病:当前的生物学和治疗方法。
Rev Neurol (Paris). 2022 Apr;178(4):315-325. doi: 10.1016/j.neurol.2021.06.006. Epub 2021 Jul 21.
3
Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.缺乏肌醇多聚磷酸酶 2 导致 Lafora 病中肌醇多聚磷酸酶 2 结合物和肌醇多聚磷酸酶增加,从而形成 Lafora 小体。
J Biol Chem. 2012 Jul 20;287(30):25650-9. doi: 10.1074/jbc.M111.331611. Epub 2012 Jun 5.
4
Lafora Disease: A Ubiquitination-Related Pathology.拉福拉病:一种与泛素化相关的病理学疾病。
Cells. 2018 Jul 26;7(8):87. doi: 10.3390/cells7080087.
5
Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.异常的糖原链长度模式,而非过度磷酸化,在拉福拉病中至关重要。
EMBO Mol Med. 2017 Jul;9(7):906-917. doi: 10.15252/emmm.201707608.
6
Loss of laforin or malin results in increased Drp1 level and concomitant mitochondrial fragmentation in Lafora disease mouse models.在拉福拉病小鼠模型中,缺失拉福林或malin会导致动力相关蛋白1(Drp1)水平升高以及随之而来的线粒体碎片化。
Neurobiol Dis. 2017 Apr;100:39-51. doi: 10.1016/j.nbd.2017.01.002. Epub 2017 Jan 4.
7
Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells.Laforin 对于神经元细胞内质网应激抵抗中 malin 的功能激活是必需的。
FEBS J. 2012 Jul;279(14):2467-78. doi: 10.1111/j.1742-4658.2012.08627.x. Epub 2012 Jun 8.
8
Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease.糖原积累是拉福拉病神经退行性变和自噬功能障碍的基础。
Hum Mol Genet. 2014 Jun 15;23(12):3147-56. doi: 10.1093/hmg/ddu024. Epub 2014 Jan 22.
9
Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease.Laforin/malin E3-ubiquitin 连接酶对自噬 PI3KC3 复合物的调节作用,这两种蛋白均与 Lafora 病有关。
Biochim Biophys Acta Mol Cell Res. 2020 Feb;1867(2):118613. doi: 10.1016/j.bbamcr.2019.118613. Epub 2019 Nov 21.
10
Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.在小鼠中遗传耗竭 malin E3 泛素连接酶导致拉福拉氏体和不溶性 laforin 的积累。
J Biol Chem. 2010 Aug 13;285(33):25372-81. doi: 10.1074/jbc.M110.148668. Epub 2010 Jun 10.

引用本文的文献

1
Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets.恩格列净用于拉福拉病的重新定位:一项试点临床试验及新型治疗靶点的临床前研究
Methods Protoc. 2025 May 6;8(3):48. doi: 10.3390/mps8030048.
2
Neurological glycogen storage diseases and emerging therapeutics.神经糖原贮积病和新兴治疗方法。
Neurotherapeutics. 2024 Sep;21(5):e00446. doi: 10.1016/j.neurot.2024.e00446. Epub 2024 Sep 14.
3
Clinicopathologic Dissociation: Robust Lafora Body Accumulation in Malin KO Mice Without Observable Changes in Home-Cage Behavior.

本文引用的文献

1
Lack of p62 Impairs Glycogen Aggregation and Exacerbates Pathology in a Mouse Model of Myoclonic Epilepsy of Lafora.缺乏 p62 会损害糖原聚集并加剧 Lafora 肌阵挛性癫痫小鼠模型的病理学
Mol Neurobiol. 2022 Feb;59(2):1214-1229. doi: 10.1007/s12035-021-02682-6. Epub 2021 Dec 28.
2
Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease.Gys1 反义疗法可挽救小鼠拉福拉病的神经病理学基础。
Brain. 2021 Nov 29;144(10):2985-2993. doi: 10.1093/brain/awab194.
3
Targeting Gys1 with AAV-SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models.
临床病理分离:Malin KO 小鼠在无明显笼内行为改变的情况下,出现大量 Lafora 体蓄积。
J Comp Neurol. 2024 Jul;532(7):e25660. doi: 10.1002/cne.25660.
4
Lafora Disease: A Case Report and Evolving Treatment Advancements.拉福拉病:一例报告及不断发展的治疗进展
Brain Sci. 2023 Dec 6;13(12):1679. doi: 10.3390/brainsci13121679.
5
Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis.糖原积累在肌萎缩侧索硬化症的小鼠模型中调节寿命。
J Neurochem. 2024 May;168(5):744-759. doi: 10.1111/jnc.15906. Epub 2023 Jul 4.
6
Role of Astrocytes in the Pathophysiology of Lafora Disease and Other Glycogen Storage Disorders.星形胶质细胞在拉佛拉病和其他糖原贮积症的病理生理学中的作用。
Cells. 2023 Feb 24;12(5):722. doi: 10.3390/cells12050722.
7
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy.拉佛林将马琳靶向到肌阵挛性癫痫伴碎红纤维病的糖原中。
Dis Model Mech. 2023 Jan 1;16(1). doi: 10.1242/dmm.049802. Epub 2023 Jan 6.
靶向 Gys1 用 AAV-SaCas9 减少成年多糖尿素体病和拉佛拉病小鼠模型中的致病性多聚糖体和神经炎症。
Neurotherapeutics. 2021 Apr;18(2):1414-1425. doi: 10.1007/s13311-021-01040-7. Epub 2021 Apr 8.
4
Astrocytic glycogen accumulation drives the pathophysiology of neurodegeneration in Lafora disease.星形细胞糖原积累驱动拉佛拉病神经退行性变的病理生理学。
Brain. 2021 Sep 4;144(8):2349-2360. doi: 10.1093/brain/awab110.
5
Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model.神经炎症调节剂在拉佛拉病小鼠模型中具有有益作用。
Mol Neurobiol. 2021 Jun;58(6):2508-2522. doi: 10.1007/s12035-021-02285-1. Epub 2021 Jan 14.
6
An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice.诱导型糖原合酶-1 敲除可阻止但不能逆转小鼠的拉佛拉病进展。
J Biol Chem. 2021 Jan-Jun;296:100150. doi: 10.1074/jbc.RA120.015773. Epub 2020 Dec 10.
7
Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity.抑制糖原合成作为拉福拉病的治疗方法:确定治疗时机。
Neurobiol Dis. 2021 Jan;147:105173. doi: 10.1016/j.nbd.2020.105173. Epub 2020 Nov 7.
8
Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock.神经退行性疾病的基因治疗:放慢生命时钟
Front Neurosci. 2020 Sep 18;14:580179. doi: 10.3389/fnins.2020.580179. eCollection 2020.
9
Reactive Glia-Derived Neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age.反应性神经胶质衍生的神经炎症:在拉福拉进行性肌阵挛性癫痫中随着年龄增长而进展的新特征。
Mol Neurobiol. 2020 Mar;57(3):1607-1621. doi: 10.1007/s12035-019-01842-z. Epub 2019 Dec 5.
10
Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.靶向拉罗汤加病致病性 Lafora 体的抗体酶融合物。
Cell Metab. 2019 Oct 1;30(4):689-705.e6. doi: 10.1016/j.cmet.2019.07.002. Epub 2019 Jul 25.